PharmiWeb.com - Global Pharma News & Resources

Articles

Overview for “Fertility Drug Market” Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.
The Fertility Drug market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Fertility Drug market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Fertility Drug market. The report focuses on well-known providers in the global Fertility Drug industry, market segments, competition, and the macro environment. Under COVID-19 Outbreak, how the Fertility Drug Industry will develop is also analyzed in detail in Chapter 1.7 of the report., In Chapter 2.4, we analyzed indust…
Overview for “Glucagon Market” Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.
The Glucagon market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Glucagon market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Glucagon market. The report focuses on well-known providers in the global Glucagon industry, market segments, competition, and the macro environment. Under COVID-19 Outbreak, how the Glucagon Industry will develop is also analyzed in detail in Chapter 1.7 of the report., In Chapter 2.4, we analyzed industry trends in the context of COVID-19…
Overview for “Medicare Advantage Market” Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.
The Medicare Advantage market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Medicare Advantage market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Medicare Advantage market. The report focuses on well-known providers in the global Medicare Advantage industry, market segments, competition, and the macro environment. Under COVID-19 Outbreak, how the Medicare Advantage Industry will develop is also analyzed in detail in Chapter 1.7 of the report., In Chapter…
Overview for “Bariatric Surgery Devices Market” Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.
The Bariatric Surgery Devices market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Bariatric Surgery Devices market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Bariatric Surgery Devices market. The report focuses on well-known providers in the global Bariatric Surgery Devices industry, market segments, competition, and the macro environment. Under COVID-19 Outbreak, how the Bariatric Surgery Devices Industry will develop is also analyzed in detail…
Over the course of the UK lockdown, manufacturing sectors such as pharmaceutical reaped the benefits in terms of growth. But keeping up with demand is never easy, especially amidst a global pandemic when speed of production became an ever-growing sticking point to meet the needs of scientific discovery. Having been thrust into a digital-first world, businesses in these industries have had no choice but to adapt to survive. Here, Brian Imrie, managing director of adi Facilities Engineering, evaluates how technology has played a key role within the pharmaceutical maintenance strategy, and what changes are set to make a successful stay into the future.
2020 thrust digitisation into the stratosphere across nearly every industry to speak of. With remote working and social distancing negatin…
The global population health management market is predicted to generate a revenue of over $48.1 billion by 2022, and is expected to progress at a 23.3% CAGR during the forecast period (2016–2022), as per a study conducted by P&S Intelligence.
The market is growing due to the rising prevalence of chronic diseases, surging geriatric population, increasing investments by HIT companies, Affordable Care Act, and rising spending in the healthcare sector. In terms of delivery mode, the market is divided into on-premise, web-based, and cloud-based. Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/population-health-management-market/report-sample Out of these, the web-based division is expected to contribute the largest revenue share of more than 65.0% to the popu…
High purity oxygen and nitrogen are required for industrial applications. Atmosphere of Earth is comprised of 21% oxygen and nitrogen making up around 78%, other gases like argon comprising 1 per cent.
High purity oxygen and nitrogen are required for industrial applications.  Atmosphere of Earth is comprised of 21% oxygen and nitrogen making up around 78%, other gases like argon comprising 1 per cent.  And, we need oxygen to have purity up to 99.7% for applications in various industries.  This level of purity is not available in the atmosphere so it has to be done industrially.  In order to meet the requirements for oxygen with high purity, we manufacture cryogenic air separation plant that can be used for producing oxygen with high purity. O2 is highly valued for its…
Overview for “Big Data in Healthcare Market” Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.
The study of Big Data in Healthcare market is a compilation of the market of Big Data in Healthcare broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The detailed study also offers a board interpretation of the Big Data in Healthcare industry from a variety of data points that are collected through reputable and verified sources. Furthermore, the study sheds a lights on a market interpretations on a global scale which is further distributed through distribution channels, generated incomes sources and a marginalized market space where mos…
2020 Reflections, What technology do you predict will be more widely adopted and used post-pandemic that wasn’t used before?
2020 Reflections What technology do you predict will be more widely adopted and used post-pandemic that wasn’t used before? The interesting thing about where we find ourselves in responding to the pandemic is that we haven't necessarily been using new technologies - everything we've rolled out has been solutions we've been using for many years, even decades. Remote data capture, eConsent, televisits, wearables, and decentralisation - these are all tools that have been deployed in numerous ways in clinical research before. What is new is the speed and enthusiasm with which all of these tools have been adopted to respond to the huge patient safety issues we've faced thi…
GLOBAL EXECUTIVE SEARCH & LEADERSHIP CONSULTING Borderless specializes in executive search for the Chemical Industry & its value chain, the Life Sciences industry and the Food & Drinks sector. They are trusted advisors to business leaders on the creation and management of diverse, collaborative organizations and on their careers.
When we work with Chief Medical Officers, circus metaphors abound. “It is like this,” one CMO told me, “I am trying to balance many plates, but none of them are spinning.” Another confided, “I feel like I’m juggling with fiery torches,” and yet another described her work as “performing on a trapeze with absolutely no net.” Despite these challenges, the allure to “run away” to join a biotech is undeniable. Feeling trapped in endless meetings and a constant battle…
The Covid-19 crisis has underlined the need for global data standards, such as ISO IDMP (Identification of Medicinal Products), in the life sciences sector. Remco Munnik of Iperion Life Sciences Consultancy reviews progress towards IDMP in 2020 and outlines key developments expected in 2021.
Amid the disruption of 2020, there has been huge emphasis on healthcare and the role of the pharma organisations, marketing authorisation applicants and holders (MAAs and MAHs), and of regulators, in a crisis. Speed to market (bringing relevant medicinal products, for example new vaccines, to market swiftly), yet also thoroughness in safety and quality assessments, have become paramount and visible to a much greater degree in society. Countries, governments, health care providers, entire societies are c…
Owing to the rising prevalence of diseases, soaring government and non-government initiatives and policies, and surging healthcare expenditure, the adoption of single-cell analysis is predicted to rise in the coming years. The escalating healthcare expenditure, especially in the developed nations, is resulting in a huge rise in the incorporation of single-cell analysis procedures and products, such as consumables and instruments. Moreover, single-cell genomics in disease analysis allows for better personalized treatment procedures that involve the tracking, monitoring, and treatment of patients according to their individual needs.
The other major factors boosting the demand for single-cell analysis are the surging geriatric population, growing need for personalized treatment plans, and the…
First Responders may not be direct partners in the pharmaceutical supply chain, but they are equally responsible for the safety and security of drugs. There are ways to identify that the first responder is using the drugs legally and correctly. From T3 transactions to tracking first responders or dispensers, this article explores the exit point of the supply chain in details.
A lot is known and understood about the operations of a drug supply chain in the United States, which is transforming to cope with the ever-changing requirements of the DSCSA and the drug industry in the country. While everything that the DSCSA says and the participants do root in eliminating the counterfeit drug marketing in the US, compliance standards have evolved into something more prolific than just maintaining p…
No matter what stage of pregnancy you are in, a Kegel exercise can provide you with several benefits. We recommend that you choose and do the exercises that suit you. It is very beneficial for pregnant women to do Kegel exercises during pregnancy and after birth. These exercises, Dr. It was presented to pregnant women by Arnold Kegel for strengthening and working the muscles in the pelvic area. Have you heard of Kegel training before? These types of exercises are very useful for improving some of the negative aspects of pregnancy. Therefore, we will show you some of its most important benefits and you will definitely be convinced to do them.
Kegel exercises for pregnant womenIt supports the pelvic floor muscles, organs such as the bladder, urethra, and uterus, as well as organs such…
Oxygen is the most vital non-metallic element in the planet earth’s atmosphere making up around 21% by volume and 23% by weight of the air.
Oxygen is the most vital non-metallic element in the planet earth’s atmosphere making up around 21% by volume and 23% by weight of the air. It is crucial for maintaining life on the planet as it is essential for breathing. In medical science, oxygen is very important for treatment of patients suffering from hypoxemia, low level of oxygen. Medical oxygen is used for treatment of health disorders such as asthma, COPD, sleep apnea, breathlessness, etc. It is also used in surgery, as life-support system and ambulances. Benefits Of Using Medical Oxygen Plant For getting high purity oxygen you would need a medical oxygen plant for processing atmospheric oxyg…
Do you know everything about return saleables? Do you know how to use it as a stepping stone to achieve DSCSA compliance? What are the critical success factors determining the success of verified return saleables? The article talks in details about the warehouse equipment required for VRS, the right tools required for verification, and the storage requirements during the VRS process.
The VRS-compliance deadline may have been pushed by 3 years, but following the journey to complete compliance, be it VRS or others, continues. The drug supply chain stakeholders were on their toes to get the right equipment to ensure that a delay in compliance does not come in their supply chain management. Now, they can relax and take their time for compliance. However, the need for supervision still remains.…
Want to work somewhere different? We all have clear goals to reach at Abcam, and we’re encouraged to be original in how we get there. No matter your role, be it a Credit Controller or a Lab Technician, we know that tried-and-tested doesn’t always mean best. Dare to be different, dare to be ambitious, and you’ll help us change the game in our industry.
Q&A with Marco - Research Associate, Custom solutions • Tell us a little bit about your self, role exp.I graduated with a MSc in Biotechnology last year in Italy, and I came in the UK to learn and develop new skills. In January I applied for a position as Research associate in the Custom solution department. I started working at Abcam in March. Now I am leaving the company because I decided to do a PhD. The expertise and knowledge I gain…
Distributed Ledger, even though a new entrant in the complex pharma supply chain ecology, has taken data connectivity and traceability to a new level. Here’s exploring what it is in details.
We have spoken in details about various aspects of traceability in the pharma supply chain- serialization, hierarchical data, aggregation and more- all meant to save drugs from the counterfeit market. However, owing to the ever-changing dynamics of the pharmaceutical industry and its growing complexities, it would be unfair to stick to certain technologies over time. So, as we approach the future of traceability, we have to adopt technologies designed considering the changing ecology and demands of the drug supply chain in mind. The main aim of introducing traceability, as per DQSA act, is to eliminate…